Its 2024 and cardiologists still don't know about transient constriction #SpreadTheWord #cardiotwitter

Genes with recessively inherited pathogenic variants are increasingly important in cardiomyopathies. Based on our recent meta-analysis in Nature Cardiovascular Research nature.com/articles/s4416… – the first in a series of gene synopses, focusing on the proteostasis regulator BAG5 #recessiveCMgenes

Join us and wear red for Women's Heart Health month! And join Dr Amanda Vest & Indranee Rajapreyar tomorrow! Cardiology Fellowship Training at Tufts MC Tufts Medical Center Sucharita Kher MD Helen Boucher Chloe E. Bird Michael Paasche-Orlow

Team aldactone all the way !!

Negative genetic testing for HCM and ARVD does not exclude their presence!! 🤦‍♂️ #CardioTwitter #cardiogenetics

Incredible to see familiar faces that welcomed and supported me throughout my time in this country #PHgrandrounds

🔥🔥🔥 BREAKING 🔥🔥🔥 FTC Announces the Banning of the Noncompete ftc.gov/news-events/ne…

More unnecessary cancer screening please

Final Reason -We are selecting patients least likely to benefit Patient Selection Reduces Odds of Benefit Canadian Study 2022 – Age 78 years; 1 in 6 patients died in first year NCDR Study -- Age 78 years; 9% patients died in first year NCDR-LAAO -- 90% of patients were

History made. Arteta needs a striker and then he stands a chance next season. #citychampions

Everolimus extends life and slows decline in heart function in mice with lamin A/C cardiomyopathy. ahajournals.org/doi/10.1161/CI… #AHAjournals Columbia Vagelos College of Physicians & Surgeons #CircHF

HCM pts treated w LAA occlusion had nearly double the rate of ischemic stroke vs those treated w anticoagulants. Who could have predicted this? #ReadSeminalTrials #PREVAIL #CompetingRisks

World champions again #boomboombumrah

Ice runs through his veins #masterful

A case I won't easily forget: 28-year-old (39 weeks) pregnant patient suffered in-hospital cardiac arrest during labour; secondary to amniotic fluid embolism. Emergency C-section was performed, during which we put her on VA-ECMO (ECPR).

Excited to discuss “Chemotherapy Induced cardiomyopathy” with the audience 2024 Texas Cardiovascular Innovations Conference with excellent sessions and moderation by Mahek Shah, MD #cardioonc International Cardio-Oncology Society

🚨­­ MAJOR news in the #ATTR #amyloidosis world! Today the ­­­much-anticipated HELIOS-B results were presented European Society of Cardiology & simultaneously published in NEJM. The largest ATTR-CM trial published to date, testing #vutrisiran vs. placebo. Bottom line: Huge win for vutrisiran!

The SENIOR-RITA trial found that an invasive strategy involving coronary revascularization plus medical therapy did not significantly reduce the risk of cardiovascular death or nonfatal myocardial infarction compared to a conservative medical therapy approach in older patients

Excellent points of caution wrt RESHAPE-HF2 medscape.com/viewarticle/te…

Couple of key facts about NOTION-3 when you interpret the results and try to apply its results 1) OPEN label 2)Exc significant stenosis LM or ostial LAD + ostial Lcx Absolutely no difference in procedural mortality, HF, inotrope or MCS needs PCI does not make procedure 'safer'